Chemical Structure : PLK1 inhibitor B4
CAS No.:
2991469-28-2
PLK1 inhibitor B4
Catalog No.: PC-24600Not For Human Use, Lab Use Only.
PLK1 inhibitor B4 is a novel small molecule inhibitor of polo-like kinase 1 (PLK1) with SPR KD of 5.6 uM, IC50 of 13.52 uM.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Purity & Documentation Purity:
>98% (HPLC)
Biological Activity
PLK1 inhibitor B4 is a novel small molecule inhibitor of polo-like kinase 1 (PLK1) with SPR KD of 5.6 uM, IC50 of 13.52 uM.
B4 inhibits PLK1 phosphorylation as well as decreases the abundance of PLK1 in A549/DDP and A549 cells.
B4 exhibits a potent cytotoxic activity in A549 cells with an IC50 value of 6.8 μM.
B4 specifically binds to PLK1 PBD and inhibits its activity in A549/DDP cells
B4 enhances cisplatin sensitivity in vitro and in vivo by blocking PLK1/PRC1 signaling
B4 (30 mg/kg) exhibits in vivo anticancer activity in an A549/DDP xenograft mice model, combination with cisplatin elicites dramatic regression of drug-resistant tumors.
Physicochemical Properties
|
M.Wt
|
505.51
|
|
Formula
|
C24H22F3N3O4S
|
|
Appearance
|
Solid
|
|
CAS No.
|
|
|
Storage
|
- Solide Powder
-
-20°C 12 Months; 4°C 6 Months
|
- In Solvent
-
-80°C 6 Months; -20°C 6 Months
|
|
Shipping
|
|
|
Solubility
|
10 mM in DMSO
|
|
Chemical Name/SMILES
|
2-(2-(dimethylamino)ethyl)-1,3-dioxo-N-(4-(trifluoromethyl)benzyl)-2,3-dihydro-1H-benzo[de]isoquinoline-6-sulfonamide
|
References
1. Li P, et al. Cell Death Dis. 2025 May 12;16(1):374.
Contact Us
sales@probechem.com
